Baxter International: Debt, Margin Pressure, Dreadful FY26 Guidance (Downgrade)

分组1 - Baxter International Inc. experienced a significant decline in share price following disappointing Q4 results and a negative FY 2026 guidance [1] - The company's current market capitalization stands at $9.6 billion, and it is trading with a single-digit price-to-earnings ratio, indicating potential undervaluation [1] 分组2 - The healthcare equipment industry is facing challenges, as evidenced by Baxter's recent performance, which may reflect broader market trends [1]